In addition, in April 2024, Novartis, which already has two FDA-approved PDC drugs ... get a snapshot of the Peptide-drug Conjugate Market Outlook The peptide-drug conjugate market is witnessing ...

Holdings announced its plans to advance the development of its proprietary Antibody Drug Conjugate (ADC) platform ...

In a phase 2 randomized controlled trial conducted across 70 centers in multiple countries, researchers evaluated the efficacy and safety of a novel antibody-drug conjugate, ABBV-154, in 181 ...

To read more about the latest highlights related to the PDC market, get a snapshot of the key highlights entailed in the Global Peptide-drug Conjugate Market Report Peptide-drug conjugates (PDCs) are ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...

Hong Kong health authorities have apologised for mistakenly giving pneumococcal vaccines to two children at a health centre ...

Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying China’s CSPC Megalith Biopharmaceutical $15 ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...